Skip to main content
. 2019 May 5;20(9):2210. doi: 10.3390/ijms20092210

Figure 7.

Figure 7

Flow-chart of our proposed PL-drug conjugates development process. SAR—structure-activity relationship; MD—molecular dynamics; PL—phospholipid; PLA2—phospholipase A2.